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Abstract
Background
The Lightning Process (LP), a mind-body training programme, has been applied 
to a range of health problems and disorders. Studies and surveys report a range
of outcomes creating a lack of clarity about the efficacy of the intervention.
Objective
This systematic review evaluates the methodological quality of existing studies 
on the LP and collates and reviews its reported efficacy.
Data sources
Five databases, PsycINFO, PubMed, CINAHL, Embase, ERIC (to September 
2018), and Google and Google Scholar were searched for relevant studies.
Study Selection
Studies of the LP in clinical populations published in peer-reviewed journals or in
grey literature were selected. Reviews, editorial articles and studies/surveys with
un-reported methodology were excluded.
Data extraction
Searches returned 568 records, 21 were retrieved in full text of which 14 fulfilled 
the inclusion criteria (ten quantitative studies/surveys and four qualitative 
studies).
Data synthesis and Conclusions
The review identified variance in the quality of studies across time; earlier 
studies demonstrated a lack of control groups, a lack of clarity of aspects of the 
methodology and potential sampling bias. Although it found a variance in 
reported patient outcomes, the review also identified an emerging body of 
evidence supporting the efficacy of the LP for many participants with fatigue, 
physical function, pain, anxiety and depression. It concludes that there is a need 
for more randomised controlled trials to evaluate if these positive outcomes can 
be replicated and generalised to larger populations.
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Introduction
The Lightning Process (LP) is a mind-body training programme hypothesised to 
help individuals to develop a more conscious influence on their neurological 
function and affect change in physiological processes.1
To provide ease of access, the program is delivered via a 4 hr audio home-study
program with 1 hr of phone coaching, as preparation for the 3 training seminars 
(4 hr each) with a registered practitioner, which are delivered face to face or 
online with 3–8 attendees. It was devised in a similar way to other novel 
approaches, such as Motivational Interviewing,2 through an iterative process of 
practice-based evidence3 and qualitative inquiries into clients’ experience, and 
its name was suggested by reports of the rapidity of change, as noted 
subsequently by participants in other studies.4 It was developed from concepts 
from Positive Psychology, health education theory, mindfulness, osteopathy, 
coaching and Neuro-Linguistic Programming (NLP).
It has two phases 1) teaching core concepts and 2) adopting practical tools. In 
phase 1, participants are presented with relevant theory and research to 
understand how the mind-body connection can be utilised in order to influence 
physiology.5 Particular attention is paid to how language can affect neural 
pathways1,6 and the role that patient activation and empowerment,7,8 chronic 
stress and response expectancy have on physiology.9,10 In phase 2 participants 
learn a set of steps to a) detect disempowering language, negative expectancies
and changes in physiology11; b) pause by employing an interruptive ‘stop’ 
process12,13 and c) make an active choice to employ a set of self-coaching 
interventions. The self-coaching includes developing self-compassion14 and a 
series of questions designed to identify immediate goals and desired 
physiological states (to replace those identified in step a). The process is 
completed by the savouring of positive memories15 that recall previous 
experiences of those goals and states, combined with the use of body 
movements and voice tone and speed,16,17 congruent with those memories, to 
encourage improved physiology.
It has been applied to a range of issues, e.g. Multiple Sclerosis, Chronic Fatigue 
Syndrome/Myalgic Encephalomyelitis (CFS/ME), Complex Regional Pain 
Syndrome, Chronic Pain and Fibromyalgia, as well as a range of emotional and 
cognitive issues such as anxiety, depression, dyslexia and dyspraxia.1,18 It has 
grown, from its inception in the UK in 1999, to be available in 16 countries and 
by 2018 had been used by over 23,000 participants.1
Early anecdotal reports of positive outcomes from some participants and poor 
outcomes from others19 resulted in differing perceptions of the LP´s efficacy. 
These reports led to a research interest in the approach, although early 
investigations used a variety of research methods, producing highly varied 
reports of efficacy and resulting in a lack of clarity amongst stakeholders as to 
the intervention's value.
The absence of an overview of these studies results and detailed objective 
commentary on the quality of each study has further contributed to this lack of 
clarity.
This systematic review aims to resolve this by examining the quality of the 
evidence base, the studies’ designs and by reviewing the reported efficacy of the
intervention. It contextualises and explores the studies’ contribution to 
understanding the efficacy of the intervention, and using a descriptive 
narrative20 provides a synthesis of the research outcomes, its limitations and 
suggestions for future research.
Methods
The protocol for this review was registered with Prospero21 reference: 
CRD42018104336 and this report conforms to the recommendations from the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement
(PRISMA)22 (see Fig. 1).
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Fig. 1. PRISMA 2009 Flow Diagram for Systematic Review.
Search strategy
Five electronic reference databases (PsycINFO, PubMed, CINAHL, Embase, 
ERIC) were searched for the phrase “Lightning Process” in all fields/text. In 
addition, the authors also conducted manual searches in Google Scholar and 
Google. The search terms used for this were “Lightning Process” and “Lightning 
Process” AND ‘study’ OR ‘survey’ OR ‘health’. No date limit was set and articles 
in all languages were included.
Selection criteria and study selection
The selection criteria are collated in Table 1. Quantitative studies and surveys, 
including those with cross-sectional designs, qualitative studies and mixed 
methods studies specific to the Lightning Process intervention published in peer-
reviewed journals and grey literature were included. Results were required to 
include relevant uses of the phrase ‘Lightning Process’ that referred to studying 
this intervention and records that did not meet this criterion were excluded (e.g.; 
Production of perchlorate by laboratory simulated lightning process; the lightning
process in thunderstorms).
Table 1. Selection criteria.
P Population using the Lightning Process
I Lightning Process
C NA
O Identify research studying this intervention
S
Cross-sectional designs, qualitative studies and surveys and mixed methods studies published in 
peer-reviewed journals.
Non-peer reviewed articles on surveys or outcome measures studies with a reported methodology.
The Google searches produced over 42,000, mostly non-relevant results, and 
issue noted by others.23,24 Therefore, the evaluation was limited to the first 70 
results, which provided an adequate buffer to capture key relevant results.
Duplicate records were removed and additional records were searched for in the
references of the selected records.
Search results
The reference database searches provided a small set of results 
(PsycINFO = one, PubMed = eight, CINAHL = eight, Embase = eight, 
ERIC = nine). With the addition of Google and Google Scholar searches a 
further 560 results were returned.
Six studies were identified from the references of these results and 32 duplicates
were removed. This produced a total of 568 records (see Fig. 1) with 21 records 
identified as potentially eligible and retrieved in full text. Seven studies did not 
evaluate the LP and were excluded, resulting in a total of 14 studies meeting the
inclusion criteria.
Data collection, analysis and quality assessment
Two authors (PP, JA) read and re-read the papers in their entirety and assessed 
the methodological quality of the selected studies dependent on the study type 
as suggested by other researchers.25., 26., 27., 28., 29. For evaluating the 
qualitative studies four review areas (1. Phenomenon studied and context; 2. 
Ethics; 3 Data collection, analysis and potential researcher bias; 4. Policy and 
practice implications) suggested by Long and Godfrey30 were used. The 
quantitative studies were assessed with the NIH study quality assessment 
tools,31 and the five criteria (1. Clarity of aims and objectives; 2. Appropriateness
of research design; 3. Clarity of research process; 4. Relationship of data to 
results; 5. Appropriateness of method of analysis) identified by Dixon-
Woods25 were used for quantitative surveys.
Any areas identified by these tools as possible sources of bias were evaluated 
as to their potential effect on the results reported. Following the suggestion by 
Dixon-Woods25 to capture the maximum data for review, any rated as ‘poor’ 
were to remain within the review but be identified as such in the analysis.
Although all 14 studies passed this assessment (see Table 2) potential 
limitations were identified, which are detailed in the limitations section.
Table 2. Overview of studies.
Author/Year Title Country Method
Peer 
reviewed/
controlled
(PR/C)
N Age group Quality
Finch, 2010 LP Snapshot Survey of clients' experiences INTL Survey x 1297
Not 
reported Fair
ME 
association, 
2010
Managing my M.E UK Survey x 4217 All Fair
Sussex & Kent 
ME/CFS 
Society, 2010
ME/CFS Patients Survey UK Survey x 457 Not 
reported
Fair
F0nneb0 et al., 
2012
Worst Cases Reported to 
the NAFKAM 
International Registry of 
exceptional Courses of 
disease
Norway Case report x 5 Not reported Good
Sandaunet & 
Salamonsen, 
2012
CFE-/ME-pas i enters 
ulike erfaringer med 
Lightning Process.
Norway Qualitative PR 22 Adult Good
Bringsli et al., 
2013
The Norwegian ME 
Association national 
survey
Norway Survey x 1096 All Fair
Finch, 2013 Outcome measures study UK Quantitative x 205 All Good
Reme, Archer 
& Chalder, 
2013.
Experiences of young 
people who have 
undergone the Lightning 
Process to treat chronic 
fatigue syndrome/myalgic
encephalomyelitis - a 
qualitative study.
UK Qualitative PR 9
Adolescen
t
Good
Crawley et al., 
2013
The feasibility and 
acceptability of 
conducting a trial of 
specialist medical care 
and the Lightning Process
in children with chronic 
fatigue syndrome: 
feasibility randomized 
controlled trial (SMILE 
UK Qualitative PR 56 Adolescen
t
Good
Author/Year Title Country Method
Peer 
reviewed/
controlled
(PR/C)
N Age group Quality
study)
Finch, 2014
Lightning Process & 
Multiple Sclerosis: Proof 
of Concept Study
UK Proof of Concept x 11 Adult Fair
Hagelsteen & 
Moen Reiten, 
2015
Evaluation of a treatment 
strategy Norway Quantitative x 12
Adolescen
t Good
Landmark et 
al., 2016
Chronic fatigue syndrome
and experience with the 
Lightning Process
Norway Survey PR 196 All Fair
Kristoffersen et
al., 2016
Use of complementary 
and alternative medicine 
in patients with health 
complaints attributed to 
former dental amalgam 
fillings
Norway Survey PR 324 Not reported Good
Crawley et al., 
2017
Clinical and cost-
effectiveness of the 
Lightning Process in 
addition to specialist 
medical care for 
paediatric chronic fatigue 
syndrome: randomised 
controlled trial
UK
Randomise
d Controlled
Trial
PR/C 100 Adolescent Good
Results
Structure of the review
The reviewed studies were categorised as; (1) qualitative studies and case 
reports; (2) quantitative surveys and (3) quantitative non-survey studies. 
Guidance on synthesising the results of systematic reviews involving a complex 
range of un-uniform study designs led to the utilisation of a narrative and a 
descriptive presentation of the results framed by these categories in 
chronological order.20,32
Studies’ design and methodology
All the studies were undertaken in the UK and/or Norway between 2010 and 
201819,19,33 (Table 2). The sample sizes ranged from five, in the report from 
Fønnebø, Dragset & Salamonsen34 to 4217 in the study from the ME 
Association.19 Four studies focused on young people/adolescents, four included 
participants from all age ranges, two studies focused on adults and four did not 
specify age ranges. In all of these studies that reported, gender there were more
female than male participants. For studies involving CFS/ME the range reported 
was from 76%35 to 95%4 females. This skewed gender representation was also 
found in the other studies, although to a lesser degree with 71% for the study 
from Kristoffersen et al.,36 67% for the study from Finch37 and 58% for the study 
from Hagelsteen & Moen Reiten.38 Race distribution was not reported in any of 
the studies, with the exception of those related to the RCT from Crawley et 
al.,18 where participants identified themselves as British.
Qualitative studies
Sandaunet & Salamonsen, 2012. A qualitative study of CFS/ME patients’ 
different experiences with Lightning Process recruited participants via the 
Norwegian National Research in Complementary and Alternative Medicine 
(NAFKAM) and their Registry of Exceptional Illness (RESF) .4
The participants (N = 22, 95% female) self-reported 10–26 months after the LP-
course that they had experienced:
1)
Significant improvement (n = 13)
2)
No response (n = 6)
3)
Adverse response (n = 3)
Responses were analysed using a grounded theory-based process. Three 
themes of differentiation emerged; “(a) the response to the theoretical basis and 
the basic principles of the LP (b) experiences of course leader and (c) the body's
response to the LP” .4(p1) The study identified that trust and communication were
important. Those reporting an initial positive response to the LP expressed that 
they had a greater insight into their illness, that they could trust their trainer and 
that the positive physical effect of the LP continued after the seminar. These 
factors were not seen with the other respondents.
Fønnebø et al., 2012. The NAFKAM institute instigated a protocol in December 
2011 to create a warning notice for health authorities if they received three 
negative reports for an alternative treatment from patients with the same 
condition.39 As a result, they reported that three patients with CFS/ME had 
described how they experienced a strong relapse of their symptoms 6 to 12 
months after LP, which they all related to the seminar.34
Reme, Archer & Chalder, 2012. A qualitative study evaluated the experiences 
of nine young people (female = 89%, age range 14–26), who had undergone the
LP to treat CFS/ME. 40 The opportunistic sample was recruited through the 
website Association of Young People with ME (AYME) in the UK and data were 
collected by semi-structured interviews.
Seven adolescents reporting being satisfied and were much or very much better,
and two reported lack of satisfaction and absence of improvement.
Helpful aspects of the approach reported included; the theoretical rationale 
behind the intervention, the techniques they learned and the practical exercises. 
Less helpful aspects reported were the short duration and intensity of the LP and
little follow-up and, for some, the perceived secrecy surrounding the LP. The 
study noted how the requirement that participants apply the LP tools as a route 
to recovery was experienced as a sense of being blamed for lack of change by 
the two participants who noticed no benefit from the intervention.
Crawley et al., 2013. A pilot randomised trial (N = 56, female = 76.4%, mean 
age = 14.8 years (SD = 1.6), age range 12–18) was undertaken in the UK to 
evaluate feasibility and acceptability of the recruitment, randomisation and 
intervention.35 The study used an integrated qualitative methodology and found 
that recruitment, randomisation and interventions were feasible and acceptable. 
Several changes were suggested by participants to improve the experience and 
value of taking part in the study. These included more appropriate data collection
measures (Chalder Fatigue Scale41) and SF-36 physical function 
subscale,42 rather than school attendance and data collection by phone calls.
Quantitative surveys
Finch, 2010. A survey, carried out in the UK and Norway, evaluated experiences
of the LP intervention at the end of the third day of the seminar33 (N = 1297, 
female = 78.5%. Reported issues: ME/CFS 84%, depression 34%, anxiety 56%, 
low self-esteem 57%, guilt 43%).
Results for the question ‘Did you get the changes you wanted?’ are in Table 3. 
0.2% of the respondents reported that they still had issues because the training 
was ‘not good enough or was inappropriate for their needs’.
Table 3. Did you get the changes you wanted? Score your answer out of 10 
(0 = definitely no, 10 = definitely yes).
Score Given 0 1 2 3 4 5 6 7 8 9 10
No. of respondents 0 1 0 11 10 32 39 94 188 223 683
Score Given 0 1 2 3 4 5 6 7 8 9 10
% of 1281 respondents 0% 0.1% 0% 0.9% 0.8% 2.5% 3.0% 7.3% 14.7% 17.4% 53.3%
No. of those with 
CFS/ME 0 1 0 9 7 26 27 77 145 187 601
% of 1080 respondents 0% 0.1% 0% 0.8% 0.65% 2.4% 2.5% 7.1% 13.4% 17.3% 55.65%
ME Association, 2010. A UK based charity survey (N = 4217, female = 78% 
age range 11–66), asked respondents about their experiences of managing their
ME.19 Perceptions of using 25 different approaches, including standard 
approaches, such as Cognitive Behavioural Therapy (CBT) (n = 997), Graded 
Exercise Therapy (GET) (n = 906) and the LP (which was the third least used of 
the approaches, n = 101) were rated on a Likert scale.
The survey found that the LP received the highest percentage out of all the 25 
approaches for those feeling they had ‘greatly improved’. A summary of the 
reported results is presented in Table 4.
Table 4. Results of ME Association Survey, 2010.
Category Intervention
LP (n = 101) CBT (n = 997) GET (n = 906)
Greatly 
Improved 25.7% 2.8% 3.4%
Improved 18.8% 23.1% 18.7%
No Change 34.7% 54.6% 21.4%
Worse 7.9% 11.6% 23.4%
Much 12.9% 7.9% 33.1%
Sussex & Kent ME/CFS Society, 2010. Brighton & Sussex Medical School and 
the Sussex & Kent ME/CFS Society evaluated the experiences of 457 with CFS 
(mild 29%, moderate 54%, severe 16%, very severe 1%; female 77%; n surveys
sent = 900).43 Respondents categorised 16 treatments as ‘very helpful’, 
‘reasonably helpful’ or ‘not at all helpful’. The LP received the highest percentage
out of all the approaches in the ‘very helpful’ category and a summary of the 
reported results is presented in Table 5.
Table 5. Results of Sussex & Kent ME/CFS Society Survey, 2010.
Category Intervention
LP CBT GET
Very helpful 44% 24% 12%
Reasonably 
helpful 36% 50% 51%
Not at all helpful 20% 26% 37%
Bringsli et al., 2013. The Norwegian ME Association surveyed members and 
visitors to its website (N = 1096, 85% female, age range 11–80+). One question 
requested the reported effects of 18 interventions,44 using a Likert scale. A 
summary of the reported results is presented in Table 6.
Table 6. Results of Norwegian ME Association Survey, 2013.
Category Intervention
LP (n = 166) CBT (n = 368) GET (n = 328)
Greatly 
Improved 8% 2% 1%
Improved 13% 13% 13%
No Change 30% 63% 20%
Worse 22% 14% 41%
Much Worse 27% 8% 25%
Kristoffersen et al., 2016. This study evaluated the ‘use of complementary and 
alternative medicine in those with health complaints attributed to former dental 
amalgam fillings’36 using data from the Norwegian Dental Patient Association 
(NDPA) (N = 324, female = 71.6%) and includes reported responses to the LP 
(n = 16), with six reporting good effect, seven reporting no change, none 
reporting a worsening and three non-responders.
Landmark et al., 2016. A call for research45 published in the Journal of the 
Norwegian Medical Association reported on a survey evaluation of participants 
(N = 196, age range 10–76) attending the LP in 2008.46 Data collected through 
phone interviews used a structured questionnaire. The majority of participants 
reported increased activity level (from 3 to 7 on a Likert scale from 1 to 10, 
where 10 is normal/high level of activity), school and work attendance (from 17%
to 60%), time in bed/sofa (from 15 h to 10 h per day) and better life quality (from 
3 to 7 on a Likert scale from 1 to 10, where 10 is best). The improvement, 
compared to baseline, lasted more than a year after the LP. There were no 
reports of serious adverse effects.
Quantitative studies (non-survey)
Finch, 2013. An interim report was published on an outcome measures, cross-
sectional study of LP participants47 (N = 205, female = 80%, mean age = 37.4 
years (SD = 15.6), age range 9–73) using RAND SF-36.42 The most frequent 
self-reported reasons for attendance were CFS/ME (64.4%), anxiety/depression 
disorders (17.1%), Multiple Sclerosis (2.9%) and Fibromyalgia (2.9%). Repeated
measures ANOVA using Time of Testing (three levels; pre-test, six weeks, three 
months) were used to analyse: health change, physical functioning, role 
limitations due to physical health, role limitations due to emotional problems, 
energy/fatigue, emotional well-being, social functioning, pain and general health.
The participants reported a significant difference in all sub-scales of RAND SF-
36 (p < .0001) indicating that the LP is associated with positive change on all 
dimensions of health tested by RAND SF-36. The significant improvement in 
health status persisted in all scales, except the emotion-related measures, at six 
weeks and three months (p < .0001).
Finch, 2014. A proof of concepts study in conjunction with the Multiple Sclerosis 
Research Council (MSRC) evaluated if the LP could improve outcomes for those
with MS.37 Participants (N = 11, female = 7) were recruited by MSRC in the UK. 
RAND SF36,42 Functional Assessment of MS scale (FAMS)48 and Fatigue 
Severity Scale (FSS)49 questionnaires were completed at four time intervals: 
prior to and six weeks, three and six months after attending the LP seminar. 
Seven participants remained in the study at the six-month stage, and as a result,
missing data were excluded from the analysis. Analysis showed improvements 
in all sub-scales of the RAND SF-36 at all data collection points, with 
energy/fatigue levels, general health, role limitations due to emotional problems 
and emotional well-being showing the greatest change. The MSRC commented 
that, although the study was of a small scale the results indicated that the LP 
provides measurable benefits to those with MS.50
Hagelsteen & Moen Reiten, 2015. A small-scale treatment evaluation of 
adolescents (14–18 years) with chronic headaches (N = 12, female = 7) was 
undertaken in Norway.38 Pain levels were evaluated using the Visual Analogue 
Scale51 and analysis showed that pain was significantly reduced for nine of the 
participants at three months and this change was maintained at 12 months. The 
majority also had improved quality of life, were more active and more able to 
spend time with friends and there was a significant increase in school 
attendance. The number of participants ‘always / almost always in school’ had 
increased from three prior to the LP to eight at one-year post LP.
Crawley et al., 2017. The Specialist Medical Intervention and Lightning 
Evaluation (SMILE) RCT (N = 100) run by the UK's NHS and University of Bristol
compared Specialist Medical Care (SMC) (n = 49) to SMC plus LP 
(n = 51).18 SMC comprised a range of approaches including sleep and activity 
management, CBT for anxiety and low mood and GET. 12–18 year olds (mean 
age = 14, 76% female) with mild/moderate CFS/ME were recruited for the study.
The study found those receiving SMC plus LP had improved physical function at 
six months compared to those receiving SMC, with an adjusted difference in 
means 12.5 [95% CI 4.5, 20.5], p = .003), and at 12 months this had increased 
to 15.1 (95% CI 5.8, 24.4, p = .002). Those in the SMC plus LP had a greater 
reduction of anxiety symptoms measured by both the Hospital Anxiety and 
Depression Scale (HADS)52 (−3.3, [95% CI −5.6, −1.0], p = .005) and the 
Spence Children's Anxiety Scale (SCAS)53 (−8.7, [95% CI −16.9, −0.5], p = .039)
at six months, and that continued at 12 months. Results also showed a reduction
in depression in participants in the SMC plus LP arm compared to those in the 
SMC arm at 12 months (adjusted difference in means in HADS depression score
−1.7 [95% CI −3·3, −0·2] p = .030). Pain scores were reduced in participants 
receiving SMC plus LP compared with those receiving SMC at both six and 12 
months, but confidence intervals were wide and unreported. Those in the SMC 
plus LP arm had improved school attendance at 12 months compared to those 
receiving SMC (adjusted difference in means 0.9 days of school per week [95% 
CI 0.2, 1.6] p = .018). Additionally, it reported evidence that combining SMC with 
LP was more cost-effective than delivering SMC on its own. This considered the 
reduced costs of using the NHS as a result of improvement (which was not 
shown by the study) and increase in health-related quality of life (which was 
shown by the study), measured by QALYs, derived from the EQ-5D-Y.54
Although nine participants reported a worsening of symptoms at six months 
(eight in SMC arm, one in SMC + LP arm), five of these nine had deterioration of
≤10 on the SF-36 physical function subscale (range 0–100) which is considered 
to be less than the minimal clinically important difference. Notability none of the 
participants in the SMILE trial had any serious adverse events attributable to 
receiving either SMC or SCM plus LP, which is a valuable finding for assessing 
benefits to risk ratios.
In January 2018 the journal editors were contacted with concerns that the paper 
‘lacked sufficient detail and clarity for readers to fully understand the study as 
conducted.’55 An extensive clarification process was undertaken with the authors
to address these concerns. This resulted in the publication of a revised version 
of the paper with ‘extensive clarifications to the study's timeline and 
methods’55 which, the editors concluded, addressed the criticisms raised.
Discussion
This is the first systematic review to evaluate the quality of the evidence base 
and collate and review the research on the LP. It presents a timeline of the 
research as the approach moved from one of practice base evidence, through 
anecdotal case reports to surveys and finally to peer-reviewed studies, 
culminating in a well-conducted RCT. There are a number of findings that can be
drawn from this review; first, the evidence base is in its early stages, with the 
first studies appearing in 2010. Second, the quality of the studies has developed 
with time, with earlier studies being mainly uncontrolled surveys, with potential 
issues of bias and the later studies being of higher quality, with clearer 
methodology, and in the case of the RCT, randomisation and controlling 
elements.
Limitations
The following limitations are recognised in this review. Several databases were 
searched, however, others that might have been valuable to include, such as 
Amed, were not included. Although this had the potential to exclude relevant 
studies, it was considered that the Google and Google Scholar searches would 
provide adequate access to studies in journals represented by Amed.
To increase the quality of the review, opinion pieces, forum and blog posts, 
books, newspapers and magazine articles were excluded,56,57 but it could be 
argued that the addition of non-peer-reviewed studies in this review has the 
potential to lower the quality of the findings. Issues arose from potential bias in 
selection of participants, which were acknowledged particularly by the authors of
the surveys from the ME charities.19,43,44 Sample sizes, a lack of detail of power 
calculations and statistical analysis were of concern in selected papers, 
including the small sample size of three respondents in the NAFKAM 
report,34 issues of comparing interventions when the samples sizes for each 
intervention were different19,44,58 and from high attrition levels, such as Finch's 
2014 MS study. The surveys reported participants’ experiences at one time 
point, Finch's 2010 survey, for example, being undertaken shortly after attending
the LP, and are thus limited in assessing longevity of effects. Additionally, 
limitations common to surveys, concerning self-report and lack of information 
about clarity of diagnosis,59,60 an issue that is the cause of strong debate in 
CFS/ME studies,61,62 may affect the quality of the included studies.
In the qualitative studies, the positive or negative outcomes were described, as 
is usual practice, by self-report. As a result, these naturally lack confirmation 
through validated measures and have the potential to ascribe cause and effect 
where it may not be appropriate, particularly where the effect is reported 6–12 
months after receiving an intervention.4,34 However, it was decided that 
maintaining an awareness of, and commenting on the research quality, justified 
their inclusion and in turn increased the comprehensiveness of this review. As 
with other studies reporting one author (PP) as the originator of the intervention 
central to the studies being reviewed, the potential for bias was recognised and 
a series of reflexivity procedures as suggested by researchers63,64 were 
implemented by the authoring group during all phases of the study to ameliorate 
this.65
Outcomes of the LP
The studies showed that there was a range of participant's responses to the LP. 
However, the most robust study reported here, the RCT,18 and the non-survey 
quantitative studies, reported significant outcomes in a range of measures. 
Additionally, all the studies and surveys in the review identified a level of benefit 
from the intervention. Given the range of conditions participants presented with, 
this suggests that the LP has a broad degree of applicability.
The studies also suggest that positive outcomes were not experienced by all, 
and in the qualitative studies and earlier surveys, a worsening was reported by 
some.4,34,40 However, the RCT18 did not find any adverse events attributed to 
either the SMC or SMC +LP arm of the trial. Although reports of worsening after 
treatment is a finding seen in studies on other interventions for 
CFS/ME,19,34,66 these reports highlight issues for the LP organisation to reflect 
on and learn from. These include the reports of issues of practitioner 
communication, with some participants reporting feeling blamed or instructed to 
ignore symptoms,4,34,40 although a language barrier might be an issue in these 
two 2012 Norwegian studies, where the seminars were delivered in English to 
Norwegian speakers. While this sense of blame is counter to published materials
on the LP approach,1,8,67 it raises issues with communication, or understanding, 
of the core concepts, which the organisation and practitioners have reportedly 
have begun,68 to take action to address. This variability in responses raises 
important research questions as to why the LP is reported to have a statistically 
significant effect in a variety of standardised measurements and no change for 
others.
Clarity about the LP
The review also notes the variance and accuracy of reporting of the mechanics 
and aims of the process.4,40,45,69 It is anticipated that the recent paper on the LP 
hypothesis1 and the publication of this review will encourage discussion between
researchers and those directly involved in the LP to ensure more clarity of 
description for future studies.
Conclusion
In conclusion, this review identified that there is a developing body of evidence 
supporting the efficacy of the LP for many participants, although it found a range
of reported outcomes to the intervention and a variance in the reported 
descriptions of the mechanics of the approach. There is a variance in the design 
and quality of the studies, with the more recent studies being of higher quality 
and better designed than earlier, non-peer-reviewed ones.
Research to date points to the LP as a developing field of interest which 
potentially provides additional solutions to a range of illnesses with currently 
poor treatment outcomes. It is also clear that more research is needed with 
larger populations to 1) identify who would most benefit from the approach, 2) 
further evaluate its efficacy, ideally by comparing the LP to a single intervention, 
to identify if the results of the RCT can be replicated on a larger scale and with 
adult populations and 3) explore the accuracy of its hypothesised mechanisms 
with a range of biochemical and functional imaging investigations.
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